Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
4.900
-0.170 (-3.35%)
Nov 21, 2024, 4:00 PM EST - Market closed
Nuvectis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 91 | 145 | 110 | - | - |
| Market Cap Growth | -47.15% | 31.58% | - | - | - |
| Enterprise Value | 77 | 122 | 86 | - | - |
| Last Close Price | 5.07 | 8.34 | 7.50 | - | - |
| PB Ratio | 8.76 | 11.84 | 7.72 | - | - |
| P/TBV Ratio | 10.67 | 11.84 | 7.72 | - | - |
| Quick Ratio | 2.72 | 2.74 | 3.23 | 2.37 | - |
| Current Ratio | 2.74 | 2.75 | 3.30 | 2.41 | - |
| Return on Equity (ROE) | -140.00% | -168.51% | -206.81% | -609.74% | - |
| Return on Assets (ROA) | -60.86% | -69.14% | -83.30% | - | - |
| Return on Capital (ROIC) | -87.00% | -103.60% | -122.14% | -171.30% | - |
| Earnings Yield | -21.82% | -15.40% | -17.38% | - | - |
| FCF Yield | -15.35% | -11.04% | -12.35% | - | - |
| Buyback Yield / Dilution | -10.23% | -22.90% | -196.55% | -9.44% | - |
| Total Shareholder Return | -10.23% | -22.90% | -196.55% | -9.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.